What does glutathione do in the body?
Glutathione is a tripeptide — three amino acids (glycine, cysteine, and glutamate) joined together — that the body synthesizes inside cells. It serves three main functions:
- Direct antioxidant neutralization: Glutathione donates an electron to neutralize reactive oxygen species (free radicals). It is then regenerated to its active form (GSH) by glutathione reductase using NADPH, allowing it to cycle continuously.
- Phase II liver detoxification: The liver conjugates glutathione with potentially harmful compounds via glutathione S-transferases, making them water-soluble for excretion. This pathway handles a wide range of environmental toxins, metabolic byproducts, and certain medications.
- Immune function support: Glutathione maintains the redox state of immune cells, including lymphocytes and macrophages. Oxidative stress depletes glutathione in immune cells and impairs their function. Research shows that T-cell proliferation in response to antigens is glutathione-dependent.
Intracellular glutathione declines with age, chronic illness, alcohol use, acetaminophen use (which consumes glutathione in hepatic metabolism), and persistent oxidative stress. Parenteral glutathione administration is used clinically to support these depleted pools when dietary precursors and oral supplementation are insufficient.
Why isn’t oral glutathione enough?
The digestive tract is the main obstacle. Glutathione taken orally is exposed to proteolytic enzymes in the stomach and small intestine that cleave the tripeptide bond, releasing the three constituent amino acids rather than delivering intact glutathione to systemic circulation.
Standard oral glutathione capsules have low bioavailability as a result. Some of the absorbed amino acids — especially cysteine — do serve as glutathione precursors inside cells (and this is the rationale for N-acetylcysteine, which efficiently raises intracellular glutathione by providing cysteine). But intact glutathione delivery to tissues is minimal through this route.
Liposomal oral formulations encapsulate glutathione in lipid vesicles that protect it from GI degradation and improve systemic delivery. A randomized trial found that liposomal glutathione supplementation raised whole blood and tissue glutathione more effectively than conventional oral formulations. But even liposomal oral glutathione delivers less than parenteral routes, and the cost per effective dose is often comparable to or higher than subcutaneous administration via compounding.
What does IV glutathione infusion involve?
IV glutathione is administered directly into a vein, typically over 15 to 30 minutes, at an infusion clinic. This bypasses all GI absorption entirely, delivering a large bolus directly into systemic circulation. Peak plasma concentrations are high immediately following infusion.
The practical constraints:
- In-person clinic visit required. Every administration requires a clinic appointment, IV placement, and monitoring time. For most patients, this means weekly or biweekly visits.
- Cost per session. Clinic IV glutathione typically costs $100–200 per session depending on location and dose, not including clinic consultation fees. For regular protocol use, this adds up.
- Rapid distribution and clearance. Glutathione has a short plasma half-life. High peak concentrations from IV infusion are followed by relatively rapid clearance; less of the administered dose may reach intracellular compartments compared to slow subcutaneous absorption.
- IV complications. IV access carries a small risk of phlebitis, bruising, infection at the insertion site, and discomfort. These risks are low when administered by trained professionals but are not zero.
Both routes clear the gut that destroys oral glutathione — the real question is a clinic-bound bolus versus a steadier dose you give yourself at home.
What does subcutaneous glutathione injection involve?
Subcutaneous (SQ) injection delivers glutathione into the fatty tissue just below the skin. It is the same administration route used for insulin by diabetics, semaglutide and tirzepatide in GLP-1 therapy, and many peptide protocols. Patients can self-administer following training, typically at the abdomen, thigh, or outer arm.
The trade-offs differ from IV in clinically meaningful ways:
- At-home administration. No clinic visit required for each dose. This makes consistent daily or multi-weekly dosing practical without repeated travel and appointment scheduling.
- Lower cost per dose. Compounded subcutaneous glutathione from a licensed 503A pharmacy is typically lower cost per administration than clinic IV sessions when amortized over a consistent protocol.
- Slower, more sustained absorption. The subcutaneous depot releases glutathione gradually rather than delivering a large bolus. This may provide more consistent systemic exposure between administrations compared to the peak-and-trough pattern of IV infusion.
- Requires proper technique and storage. Compounded glutathione vials require refrigeration, aseptic reconstitution or handling, and proper needle technique. Training is part of the onboarding for any at-home injectable protocol.
Which glutathione delivery route is better: IV or subcutaneous injection?
There is no single answer that applies to all patients. The choice depends on what you are trying to accomplish and what constraints you are working within.
| Factor | IV infusion (clinic) | Subcutaneous injection (at home) |
|---|---|---|
| Location | Clinic visit required each time | Self-administered at home |
| Absorption profile | High peak bolus, rapid clearance | Gradual, sustained release from depot |
| Cost per dose | $100–200/session + clinic fees | Lower per dose via compounding |
| Best suited for | Acute or single-session support | Ongoing protocol-based use |
| Prescription required | Yes | Yes (compounded by licensed 503A pharmacy) |
IV may be preferable when a patient wants a single-session high-dose administration for acute depletion (such as following heavy alcohol intake or acetaminophen load), when the clinical goal is rapid short-term support, or when a patient is unwilling or unable to learn self-injection technique.
Subcutaneous injection is generally preferable for ongoing, protocol-based use: it is more cost-effective, enables consistent dosing without clinic trips, and the more sustained absorption profile may be better suited to supporting chronic intracellular glutathione depletion. Most clinician-supervised glutathione protocols for longevity, detoxification support, or immune optimization use subcutaneous administration for these reasons.
The comparison is not about which route produces “better” glutathione — both deliver the molecule effectively past the oral bioavailability problem. It is about which protocol fits the patient’s life and the clinical goal.
How does glutathione therapy through PepScribe work?
PepScribe offers clinician-supervised glutathione as part of its broader wellness and anti-aging offering. Injectable formulations are compounded by licensed 503A pharmacies in the USA. No hidden overseas supply chain. A licensed clinician reviews your intake, health history, and goals before any prescribing decision.
Subcutaneous self-injection protocols with training are available for at-home use. This makes consistent long-term glutathione support practical without repeated clinic visits. You are not charged for medication unless it is prescribed following clinician review.